14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ELEV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Elevation Oncology, Inc. stock price on Wednesday which ended trading at $4.00
(Updated on May 01, 2024)

Sell candidate since Apr 15, 2024 Loss -9.71% PDF

The Elevation Oncology, Inc. stock price gained 12.68% on the last trading day (Wednesday, 1st May 2024), rising from $3.55 to $4.00. During the last trading day the stock fluctuated 30.32% from a day low at $3.43 to a day high of $4.47. The price has fallen in 6 of the last 10 days and is down by -3.38% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 619 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $10.62 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.79% during the next 3 months and, with a 90% probability hold a price between $4.85 and $7.68 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ELEV Signals & Forecast

There are mixed signals in the stock today. The Elevation Oncology, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.43. On a fall, the stock will find some support from the short-term average at $3.84. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -22.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Elevation Oncology, Inc. stock

Elevation Oncology, Inc. finds support from accumulated volume at $3.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.04 between high and low, or 30.32%. For the last week, the stock has had daily average volatility of 15.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ELEV) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Elevation Oncology, Inc. to open at $3.97, and during the day (based on 14 day Average True Range), to move between $3.55 and $4.45, which gives a possible trading interval of +/-$0.455 (+/-11.37%) up or down from last closing price. If Elevation Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 22.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.85 (3.75%) than the resistance at $4.41 (10.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Elevation Oncology, Inc. stock A Buy?

Elevation Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.742 Sell Candidate Unchanged

Predicted Opening Price for Elevation Oncology, Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$3.97 ( 0.83%) $4.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ELEV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.01 25.17 %
R2 4.61 15.23 %
R1 4.36 9.10 %
Current price: 4.00
Support S1 3.57 -10.77 %
S2 3.32 -16.90 %
S3 2.93 -26.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.67 16.75 %
R2 4.50 12.50 %
R1 4.41 10.25 %
Current price 4.00
Support S1 3.85 -3.75%
S2 3.71 -7.25%
S3 3.55 -11.25%

FAQ

What is the symbol for Elevation Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Elevation Oncology, Inc. is ELEV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Elevation Oncology, Inc. Stock?
Elevation Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Elevation Oncology, Inc. Stock?
Elevation Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Elevation Oncology, Inc. Stock.

What's the current price of Elevation Oncology, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Elevation Oncology, Inc. (ELEV) share was $4.00.

What is the 52-week high and low for Elevation Oncology, Inc. Stock?
The 52-week high for Elevation Oncology, Inc. Stock is $5.89 and the 52-week low is $0.363.

What is the market capitalization of Elevation Oncology, Inc. Stock?
As of the May 01, 2024, the market capitalization of Elevation Oncology, Inc. is 194.604M.

When is the next earnings date for Elevation Oncology, Inc.?
The upcoming earnings date for Elevation Oncology, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Elevation Oncology, Inc.

Elevation Oncology. Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas... ELEV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT